Nothing Special   »   [go: up one dir, main page]

ZA201408065B - Compositions and methods for the treatment of diabetes - Google Patents

Compositions and methods for the treatment of diabetes

Info

Publication number
ZA201408065B
ZA201408065B ZA2014/08065A ZA201408065A ZA201408065B ZA 201408065 B ZA201408065 B ZA 201408065B ZA 2014/08065 A ZA2014/08065 A ZA 2014/08065A ZA 201408065 A ZA201408065 A ZA 201408065A ZA 201408065 B ZA201408065 B ZA 201408065B
Authority
ZA
South Africa
Prior art keywords
diabetes
compositions
treatment
methods
Prior art date
Application number
ZA2014/08065A
Inventor
Mahesh Kandula
Original Assignee
Cellix Bio Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Private Ltd filed Critical Cellix Bio Private Ltd
Publication of ZA201408065B publication Critical patent/ZA201408065B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA2014/08065A 2012-05-08 2014-11-04 Compositions and methods for the treatment of diabetes ZA201408065B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1788CH2012 2012-05-08
PCT/IB2013/050744 WO2013167987A1 (en) 2012-05-08 2013-01-29 Compositions and methods for the treatment of diabetes

Publications (1)

Publication Number Publication Date
ZA201408065B true ZA201408065B (en) 2016-04-28

Family

ID=54193689

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/08065A ZA201408065B (en) 2012-05-08 2014-11-04 Compositions and methods for the treatment of diabetes

Country Status (8)

Country Link
EP (1) EP2847161A4 (en)
JP (1) JP2015521174A (en)
CN (1) CN104364230A (en)
AU (1) AU2013257708A1 (en)
CA (1) CA2873084A1 (en)
SG (1) SG11201407314XA (en)
WO (1) WO2013167987A1 (en)
ZA (1) ZA201408065B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2873094A1 (en) * 2012-05-07 2013-11-14 Cellixbio Private Limited Prodrugs of anti-platelet agents
SG11201407328TA (en) * 2012-07-03 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of moderate to severe pain
JPWO2022065133A1 (en) * 2020-09-25 2022-03-31

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002034713A1 (en) * 2000-10-24 2002-05-02 Ajinomoto Co.,Inc. Process for producing b-form nateglinide crystal
CN1304366C (en) * 2002-04-15 2007-03-14 诺瓦提斯公司 Crystal forms of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine
US9085527B2 (en) * 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
US8946451B2 (en) * 2009-10-05 2015-02-03 Catabasis Pharmaceuticals, Inc. Lipoic acid acylated salicylate derivatives and their uses

Also Published As

Publication number Publication date
CN104364230A (en) 2015-02-18
EP2847161A4 (en) 2015-12-23
SG11201407314XA (en) 2014-12-30
JP2015521174A (en) 2015-07-27
WO2013167987A1 (en) 2013-11-14
EP2847161A1 (en) 2015-03-18
AU2013257708A1 (en) 2014-12-04
CA2873084A1 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
IL266582A (en) Compositions and methods for the treatment of hemoglobinopathies
HK1251796A1 (en) Methods and compositions for treating diabetes
EP2847152A4 (en) Compositions and methods for the treatment of metabolic syndrome
HK1209633A1 (en) Compositions and methods for treating diabetes
IL238177A0 (en) Methods and compositions for the treatment of cancer
ZA201408056B (en) Compositions and methods for the treatment of mucositis
EP2867239A4 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
SG11201509782TA (en) Compositions and methods for the treatment of diabetes and pre-diabetes
HK1202458A1 (en) Glucokinase activator compositions for the treatment of diabetes
ZA201408055B (en) Compositions and methods for the treatment of local pain
IL234606B (en) Novel methods and composition for treatment of disease
HRP20181761T1 (en) New alfentanil composition for the treatment of acute pain
ZA201408062B (en) Compositions and methods for the treatment of multiple sclerosis
EP2800568A4 (en) Compositions, methods of use, and methods of treatment
ZA201408065B (en) Compositions and methods for the treatment of diabetes
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
ZA201408053B (en) Compositions and methods for the treatment of metabolic syndrome
HRP20181445T1 (en) Compositions and methods for treatment of type 1 diabetes